华海药业前三季度净利3.8亿元，同比下降63.12%

Core Insights - Huahai Pharmaceutical (600521) reported a decline in both revenue and net profit for the first three quarters of 2025 [1] Financial Performance - The company's operating revenue for the first three quarters was 6.409 billion yuan, representing a year-on-year decrease of 11.57% [1] - The net profit attributable to shareholders was 380 million yuan, showing a significant year-on-year decline of 63.12% [1]